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the effect of the vaccine?
•	 My	wife	comes	in	close	contact	with	the	public	at	work;	








vaccine to the public if they are otherwise fit and 
healthy? 
•	 Can	you	give	me	unbiased	information	on	the	vaccine?	
The net has very misleading information.
By increasing awareness of our patients' vaccine concerns, 
health professionals are in a better position to proactively 
resolve consumer uncertainty and enhance compliance with 
the national vaccination strategy. If health professionals have 
difficulty answering questions on the vaccine, they can call 
the NPS Therapeutic Advice and Information Service (TAIS) 
on 1300 138 677.
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influenza H1N1 vaccine
editor, – We wish to comment on the New drugs section of 
Australian Prescriber in relation to H1N1 swine flu vaccine 
(Aust Prescr 2009;32:165−71). even before launch, Australian 
consumers were asking for information on the vaccine. Readers 
may be interested in the depth and variety of questions asked 
of pharmacists operating Medicines Line (funded by National 
Prescribing Service − NPS). This national consumer telephone 
hotline provides information about prescription, over-the-counter 
and complementary medicines. Most (82%) of the 85 questions 
received between August and october 2009 related to vaccine 
safety. A representative sample of the questions is shown below.
